INMB RSI Chart
Last 7 days
16.8%
Last 30 days
0.8%
Last 90 days
-0.7%
Trailing 12 Months
67.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 249.0K | 279.0K | 224.0K | 155.0K |
2022 | 340.0K | 356.0K | 440.0K | 374.0K |
2021 | 53.5K | 96.0K | 138.5K | 181.0K |
2020 | 0 | 0 | 0 | 11.0K |
2019 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 19, 2024 | lowdell mark william | bought | 119,999 | 8.32 | 14,423 | chief scientific officer |
Apr 19, 2024 | moss david j | acquired | 149,993 | 8.32 | 18,028 | cfo, treasurer & secretary |
Apr 19, 2024 | moss david j | bought | 149,993 | 8.32 | 18,028 | cfo, treasurer & secretary |
Apr 19, 2024 | lowdell mark william | acquired | 119,999 | 8.32 | 14,423 | chief scientific officer |
Apr 19, 2024 | juda scott | bought | 246,297 | 8.32 | 29,603 | - |
Apr 19, 2024 | tesi raymond joseph | bought | 149,993 | 8.32 | 18,028 | president and ceo |
Apr 19, 2024 | tesi raymond joseph | acquired | 149,993 | 8.32 | 18,028 | president and ceo |
Apr 19, 2024 | juda scott | acquired | 246,297 | 8.32 | 29,603 | - |
Nov 10, 2023 | juda scott | bought | 48,650 | 6.95 | 7,000 | - |
Jul 12, 2023 | schroeder timothy j | sold | -110,085 | 11.0085 | -10,000 | - |
Which funds bought or sold INMB recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Bank of New York Mellon Corp | reduced | -21.89 | -69,538 | 306,546 | -% |
Apr 25, 2024 | SIMPLEX TRADING, LLC | sold off | -100 | -23,000 | - | -% |
Apr 19, 2024 | VALLEY NATIONAL ADVISERS INC | unchanged | - | - | 11,000 | -% |
Apr 19, 2024 | Westside Investment Management, Inc. | reduced | -17.86 | -67,320 | 404,084 | 0.10% |
Apr 12, 2024 | Fermata Advisors, LLC | added | 6.88 | 38,212 | 369,549 | 0.08% |
Apr 05, 2024 | NBC SECURITIES, INC. | unchanged | - | - | 3,000 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -1.68 | 2,367,940 | 6,095,360 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 485,689 | 485,689 | -% |
Feb 14, 2024 | BANK OF AMERICA CORP /DE/ | added | 215 | 128,620 | 158,889 | -% |
Feb 14, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | added | 37.67 | 275,801 | 493,593 | -% |
Unveiling Inmune Bio Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Inmune Bio Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.6B | 6.8B | -9.03 | 6.22 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.9B | 1.8B | -42.88 | 10.32 | ||||
BMRN | 15.8B | 2.5B | 76.99 | 6.4 | ||||
INCY | 11.9B | 3.8B | 15.95 | 3.16 | ||||
MID-CAP | ||||||||
APLS | 5.6B | 396.6M | -10.5 | 14 | ||||
BBIO | 4.8B | - | -7.27 | 60.35 | ||||
AXSM | 3.5B | 270.6M | -14.83 | 13.11 | ||||
ARWR | 2.9B | 240.7M | -9.66 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -45.81 | 3.87 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 25.07 | 4.5 | ||||
NVAX | 652.2M | 983.7M | -1.2 | 0.66 | ||||
CRBP | 390.9M | 881.7K | -8.76 | 466.16 | ||||
INO | 270.2M | 4.9M | -2 | 55.51 | ||||
IBIO | 6.4M | 2.1M | -0.24 | 2.14 |
Inmune Bio Inc News
Income Statement (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q2 |
Revenue | -34.9% | 28.00 | 43.00 | 46.00 | 38.00 | 97.00 | 98.00 | 16.00 | 163 | 163 | 14.00 | - | 4.00 | 20.00 | 36.00 |
Operating Expenses | -1.9% | 8,407 | 8,571 | 6,457 | 6,461 | 5,739 | 7,541 | 6,404 | 6,641 | 9,193 | 9,035 | 6,554 | 4,552 | 3,220 | 428 |
S&GA Expenses | -7.2% | 2,400 | 2,586 | 2,309 | 2,328 | 2,329 | 2,382 | 2,215 | 2,332 | 2,125 | 2,515 | 2,090 | 2,061 | 1,361 | 1,336 |
R&D Expenses | 0.4% | 6,007 | 5,985 | 4,148 | 4,133 | 3,410 | 5,159 | 4,189 | 4,309 | 7,068 | 6,520 | 4,464 | 2,491 | 1,859 | 635 |
Interest Expenses | -17.2% | 384 | 464 | 480 | 450 | 410 | 361 | 310 | 291 | 294 | 265 | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 1.8% | -8,408 | -8,563 | -6,501 | -6,536 | -5,833 | -7,725 | -6,838 | -6,903 | -9,671 | -9,458 | -6,655 | -4,556 | -3,204 | -392 |
Net Income Margin | -58.1% | -193.60* | -122.47* | -95.32* | -108.16* | -72.99* | -70.77* | -92.33* | -96.14* | -167.62* | -172.37* | -199.29* | -272.62* | - | - |
Free Cashflow | 20.2% | -3,401 | -4,264 | -3,174 | -1,141 | -5,695 | -3,367 | -4,759 | -8,865 | -9,780 | -7,923 | -5,709 | -5,092 | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -9.1% | 57.00 | 63.00 | 70.00 | 74.00 | 82.00 | 84.00 | 88.00 | 94.00 | 100 | 108 | 61.00 | 66.00 | 41.00 | 43.00 | 23.00 | 24.00 | 24.00 | 25.00 | 28.00 | 24.00 | 17.00 |
Current Assets | -12.4% | 40.00 | 46.00 | 53.00 | 57.00 | 65.00 | 67.00 | 71.00 | 77.00 | 83.00 | 91.00 | 44.00 | 49.00 | 24.00 | 26.00 | 6.00 | 7.00 | 8.00 | 9.00 | 11.00 | 7.00 | 1.00 |
Cash Equivalents | -14.3% | 36.00 | 42.00 | 48.00 | 51.00 | 52.00 | 57.00 | 61.00 | 67.00 | 75.00 | 84.00 | 40.00 | 45.00 | 22.00 | 24.00 | 5.00 | 6.00 | 7.00 | 7.00 | 9.00 | 6.00 | 0.00 |
Liabilities | 5.0% | 19.00 | 18.00 | 19.00 | 19.00 | 22.00 | 20.00 | 18.00 | 19.00 | 20.00 | 19.00 | 17.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Current Liabilities | 28.6% | 18.00 | 14.00 | 13.00 | 10.00 | 11.00 | 7.00 | 2.00 | 3.00 | 4.00 | 5.00 | 3.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - | 1.00 |
LT Debt, Current | - | 10.00 | - | - | - | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -15.0% | 37.00 | 44.00 | 51.00 | 55.00 | 60.00 | 64.00 | 70.00 | 76.00 | 80.00 | 88.00 | 43.00 | 64.00 | 39.00 | 41.00 | 22.00 | 22.00 | 24.00 | 25.00 | 27.00 | 23.00 | 17.00 |
Retained Earnings | -7.4% | -121 | -112 | -104 | -97.55 | -91.00 | -85.18 | -77.46 | -70.62 | -63.71 | -54.04 | -44.59 | -37.93 | -33.37 | -30.17 | -25.45 | -23.35 | -21.28 | -18.96 | -15.89 | -15.50 | -13.60 |
Additional Paid-In Capital | 1.2% | 159 | 157 | 155 | 154 | 152 | 150 | 148 | 146 | 144 | 142 | 88.00 | 101 | 72.00 | 71.00 | 47.00 | 46.00 | 45.00 | 44.00 | 43.00 | 34.00 | 25.00 |
Shares Outstanding | 0.0% | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 17.00 | 15.00 | - | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 106 | - | - | - | 103 | - | - | - | 157 | - | - | - | 0.00 | - | - | - | 35.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 20.2% | -3,401 | -4,264 | -3,174 | -1,141 | -5,695 | -3,367 | -4,759 | -8,865 | -9,780 | -7,923 | -5,709 | -5,092 | -2,392 | -3,698 | -1,818 | -1,035 | -433 | -1,945 | -1,617 | -1,387 | -462 |
Share Based Compensation | -0.5% | 1,879 | 1,889 | 1,863 | 1,737 | 1,788 | 1,939 | 1,886 | 1,536 | 1,522 | 1,606 | 769 | 899 | 703 | 1,046 | 682 | 682 | 1,172 | 975 | 975 | 975 | 955 |
Cashflow From Investing | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow From Financing | -Infinity% | -2,500 | - | - | - | - | - | - | 729 | - | 52,942 | 14,951 | 28,464 | - | 23,240 | 664 | -9.00 | - | - | 4,958 | 7,251 | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
REVENUE | $ 155 | $ 374 |
OPERATING EXPENSES | ||
General and administrative | 9,623 | 9,258 |
Research and development | 20,273 | 17,067 |
Total operating expenses | 29,896 | 26,325 |
LOSS FROM OPERATIONS | (29,741) | (25,951) |
OTHER EXPENSE, NET | ||
Other expense, net | (267) | (1,348) |
Total other expense, net | (267) | (1,348) |
NET LOSS | $ (30,008) | $ (27,299) |
Net loss per common share – basic and diluted (in Dollars per share) | $ (1.67) | $ (1.52) |
Weighted average number of common shares outstanding – basic and diluted (in Shares) | 17,980,791 | 17,927,327 |
COMPREHENSIVE LOSS | ||
Net loss | $ (30,008) | $ (27,299) |
Other comprehensive loss – foreign currency translation | (100) | (700) |
Total comprehensive loss | $ (30,108) | $ (27,999) |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
CURRENT ASSETS | ||
Cash and cash equivalents | $ 35,848 | $ 52,153 |
Research and development tax credit receivable | 1,905 | 8,099 |
Other tax receivable | 537 | 362 |
Prepaid expenses and other current assets | 1,510 | 4,027 |
TOTAL CURRENT ASSETS | 39,942 | 64,675 |
Operating lease – right of use assets | 414 | 507 |
Other assets | 131 | 99 |
Acquired in-process research and development intangible assets | 16,514 | 16,514 |
TOTAL ASSETS | 57,001 | 81,795 |
CURRENT LIABILITIES | ||
Accounts payable and accrued liabilities | 7,901 | 5,206 |
Deferred liabilities | 489 | 616 |
Current portion of long-term debt, net | 9,921 | 5,000 |
Operating lease, current liabilities | 119 | 87 |
TOTAL CURRENT LIABILITIES | 18,465 | 10,918 |
Long-term debt, net | 9,697 | |
Long-term operating lease liabilities | 397 | 526 |
Accrued liability – long-term | 550 | |
TOTAL LIABILITIES | 18,862 | 21,691 |
COMMITMENTS AND CONTINGENCIES | ||
Redeemable common stock, $0.001 par value; 75,697 and 0 shares issued and outstanding, respectively (Note 9) | 799 | |
STOCKHOLDERS’ EQUITY | ||
Common stock, $0.001 par value, 200,000,000 shares authorized,17,950,776 and 17,945,995 shares issued and outstanding, respectively | 18 | 18 |
Additional paid-in capital | 159,143 | 151,799 |
Accumulated other comprehensive loss | (799) | (699) |
Accumulated deficit | (121,022) | (91,014) |
TOTAL STOCKHOLDERS’ EQUITY | 37,340 | 60,104 |
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ EQUITY | 57,001 | 81,795 |
Related Party | ||
CURRENT ASSETS | ||
Prepaid expenses – related party | 142 | 34 |
CURRENT LIABILITIES | ||
Accounts payable and accrued liabilities – related parties | $ 35 | $ 9 |